OHSU Department of Surgery
@OHSUsurgery
The OHSU Department of Surgery is a collaboration of medicine, education, research and innovation. Its residency program is one of the nation's largest.
ID:3183126141
http://bit.ly/ohsusurgery 19-04-2015 13:43:19
1,7K Tweets
3,2K Followers
571 Following
Peri-operative chemotherapy for pancreatic cancer: Quo Vadis? Nice review by rising surg onc star, Ranish Patel, and his mentor, Flavio G Rocha, MD, FACS, FSSO. link.springer.com/article/10.124… #WhyOHSUSurgery #OHSUSurgOnc
✅ out new editorial in AnnalsSurgOncology
by Ranish Patel on #NEPAFOX 🇩🇪
trial 👀ing at periop chemotx for #PDAC
OHSU Department of Surgery OHSU Knight Cancer Institute
OHSU HemeOnc Fellowship Brenden-Colson Center for Pancreatic Care
Society of Surgical Oncology IHPBA PanCAN
link.springer.com/article/10.124…
Really amazing talk Mattox/Vegas TCCACS, #tccacs by #AlbertChi who has worked to improve the lives of amputees for many years. The technology he developed is fantastic and has a high level of function. Johnny his patient came and gave a talk. OHSU Department of Surgery. Has helped many veterans!
So great to see former #HPB fellows
now serving as committee chairs at
AHPBA Executive Council meeting
OHSU Department of Surgery VM HPB Surgery
Sallie Mathews moderating the Global Surgery session at WIS, Amazing Global women here! Women in Surgery Sharona B. Ross Aurora Pryor, MD, MBA caitlin houghton Sharon Stein Jennifer Tseng (IG: @tsengjennifermd) SAGES Is In Cleveland 2024!
#SSO2024 HPB kicks the meeting off with a strong session on NGS in HPB cancers. Phenomenal presentations by Skye C. Mayo, MD, MPH on cholangiocarcinoma Cholangiocarcinoma Foundation and Susan Tsai, MD, MHS on pancreas cancer PanCAN National Pancreas Foundation
Great moderation by Yeh Lab as audience eagerly awaits more from her 🧪 🔬🧫👩🔬
Catching up with current and former OHSU Department of Surgery trainees presenting and attending #SSO2024
The future of Society of Surgical Oncology is bright 💡
OHSU Department of Surgery resident Isaac
Schwantes bringing down the 🏡 with
his 📝 on OHSU Knight Cancer Institute #HAI ⛽️ dose
reduction protocol for #CRLM from
#colorectal cancer #SSO2024 Perhaps
a strategy to ⬇️ side effects ⬆️ benefit
#ColorectalCancerAwarenessMonth
Thought-provoking talk 🗣️ #SSO2024 by OHSU Department of Surgery resident Ranish Patel on circulating hybrid cells🩸in #ColorectalCancer with OHSU Knight Cancer Institute Cancer Biology Co-Lead Dr. Melissa Wong.
🤔 applications for screening, treatment response, surveillance
#ColorectalCancer AwarenessMonth
Congrats to I-SPY2 investigators
including Dr. Arpana Naik
OHSU Department of Surgery OHSU Knight Cancer Institute
Congratulations to Dr. Issac Schwantes on his presentation at #SSO2024 . HAI infusion dose modifications may be a strategy to reduce toxicity of chemotherapy. #OHSUSurgOnc #WhyOHSUSurgery Skye C. Mayo, MD, MPH
No Tweeter >1 yr & enjoyed it 😊. Congrats to OHSU Department of Surgery resident Issac Schwantes on Society of Surgical Oncology 🗣️ on OHSU Knight Cancer Institute Modified #HAI Dose Reduction. Only safe outcomes in ⬆️📈HAI centers will 🛑 repeating the history of HAI. Modified HAI FUDR dosing: it’s a marathon, not a sprint.
How accurate are clinicians with future liver remnant volume estimations. Clinicians tend to overestimate the future liver remnant volume, especially in patients with a small future liver remnant. Great work by Skye C. Mayo, MD, MPH & team. #OHSUSurgOnc #WhyOHSUSurgery sciencedirect.com/science/articl…
Vahagn C. Nikolian, MD Joshua Davies Sean Orenstein V. Liana Tsikitis Ken Azarow Intuitive OHSU Department of Surgery BMC Surgery Jennifer Tseng (IG: @tsengjennifermd) Great event with amazing surgeons. Thanks to Vahagn C. Nikolian, MD and the rest of the group OHSU Department of Surgery for sharing your hernia wisdom and knowledge with us!
I am humbled to be selected for this. Many thanks to OHSU Department of Surgery OHSU Knight Cancer Institute LisaCoussens@CoussensLab for the ongoing support.
VertaBio is just getting started.
We will bring safe and effective CAR-T cells to patients with colorectal liver metastasis and primary PDAC. Stay tuned :-)